Transcripts
DR. ROCK:
Now, just to describe to you our first trial in a little more detail. Patients were entered from all the centers across the country and had to, in order to be considered for the trial, meet very strict criteria which meant, in some cases, we were certainly not treating the majority of patients in some centers who either presented very late in the disease or had a lot of other complications.
Of particular note, we did not treat the patients who had, at that point, impaired renal function. The reason for that is they could not be randomized to this trial because they had to be able to accept plasma infusion. And, of course, if their kidneys were shut down, this was not a reasonable thing to do.
